OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lianhua Qingke ameliorates lipopolysaccharide‐induced lung injury by inhibiting neutrophil extracellular traps formation and pyroptosis
Wenjun Peng, Hui Qi, Wensi Zhu, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 9
Wenjun Peng, Hui Qi, Wensi Zhu, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 9
Showing 9 citing articles:
Neutrophil extracellular traps and their implications in airway inflammatory diseases
Nanxia Xuan, Jie Zhao, Zhi-Ying Kang, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 6
Nanxia Xuan, Jie Zhao, Zhi-Ying Kang, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 6
Lianhua Qingke Tablet in Severe Pneumonia: Clinical Efficacy and Immunoregulatory Mechanisms
Peipei Jin, Hui Qi, Jing Zhao, et al.
Journal of Ethnopharmacology (2025) Vol. 342, pp. 119420-119420
Closed Access
Peipei Jin, Hui Qi, Jing Zhao, et al.
Journal of Ethnopharmacology (2025) Vol. 342, pp. 119420-119420
Closed Access
Targeting neutrophil dysfunction in acute lung injury: insights from active components of Chinese medicine
Saiya Ye, Lin Ma, Yayun Chi, et al.
Phytomedicine (2025), pp. 156664-156664
Closed Access
Saiya Ye, Lin Ma, Yayun Chi, et al.
Phytomedicine (2025), pp. 156664-156664
Closed Access
Targeting neutrophils extracellular traps, a promising anti-thrombotic therapy for natural products from traditional Chinese herbal medicine
Lei Wei, Xiao Li, Shanze Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117310-117310
Open Access | Times Cited: 3
Lei Wei, Xiao Li, Shanze Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117310-117310
Open Access | Times Cited: 3
Therapeutic effects of Lianhua Qingke on COPD and influenza virus-induced exacerbation of COPD are associated with the inhibition of NF-κB signaling and NLRP3 inflammasome responses
Runfeng Li, Huihuang Deng, Han Yu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113213-113213
Open Access | Times Cited: 2
Runfeng Li, Huihuang Deng, Han Yu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113213-113213
Open Access | Times Cited: 2
Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Long Coronavirus Disease (COVID) Cough: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study
Xiaolong Xu, Ying Jie, Taiping Tian, et al.
Engineering (2024) Vol. 40, pp. 61-69
Open Access
Xiaolong Xu, Ying Jie, Taiping Tian, et al.
Engineering (2024) Vol. 40, pp. 61-69
Open Access
Ameliorating lipopolysaccharide induced acute lung injury with Lianhua Qingke: focus on pulmonary endothelial barrier protection
Yan Ma, Yunlong Hou, Yu Han, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 10, pp. 6899-6917
Open Access
Yan Ma, Yunlong Hou, Yu Han, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 10, pp. 6899-6917
Open Access
Progress and Gaps in Respiratory Disease Research and Treatment: Highlights of the IRM 2024 in Shanghai
Jin‐San Zhang, Qhaweni Dhlamini, Qiang Guo, et al.
Deleted Journal (2024) Vol. 1, Iss. 4, pp. 10021-10021
Closed Access
Jin‐San Zhang, Qhaweni Dhlamini, Qiang Guo, et al.
Deleted Journal (2024) Vol. 1, Iss. 4, pp. 10021-10021
Closed Access
